- Home
- TNGX vs PFL Comparison
TNGX vs PFL Comparison
Compare TNGX & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- PFL
- Stock Information
- Founded
- TNGX 2014
- PFL 2003
- Country
- TNGX United States
- PFL United States
- Employees
- TNGX N/A
- PFL N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- TNGX Health Care
- PFL Finance
- Exchange
- TNGX Nasdaq
- PFL Nasdaq
- Market Cap
- TNGX 317.4M
- PFL 333.6M
- IPO Year
- TNGX N/A
- PFL N/A
- Fundamental
- Price
- TNGX $1.96
- PFL $8.47
- Analyst Decision
- TNGX Strong Buy
- PFL
- Analyst Count
- TNGX 7
- PFL 0
- Target Price
- TNGX $12.33
- PFL N/A
- AVG Volume (30 Days)
- TNGX 791.2K
- PFL 113.7K
- Earning Date
- TNGX 05-07-2025
- PFL 01-01-0001
- Dividend Yield
- TNGX N/A
- PFL 11.53%
- EPS Growth
- TNGX N/A
- PFL N/A
- EPS
- TNGX N/A
- PFL N/A
- Revenue
- TNGX $42,069,000.00
- PFL N/A
- Revenue This Year
- TNGX N/A
- PFL N/A
- Revenue Next Year
- TNGX N/A
- PFL N/A
- P/E Ratio
- TNGX N/A
- PFL N/A
- Revenue Growth
- TNGX 15.17
- PFL N/A
- 52 Week Low
- TNGX $1.72
- PFL $6.98
- 52 Week High
- TNGX $12.02
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- TNGX 37.66
- PFL 44.77
- Support Level
- TNGX $1.80
- PFL $8.46
- Resistance Level
- TNGX $2.01
- PFL $8.59
- Average True Range (ATR)
- TNGX 0.21
- PFL 0.05
- MACD
- TNGX 0.01
- PFL -0.01
- Stochastic Oscillator
- TNGX 31.94
- PFL 27.78
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.